Related content

Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas

By Tanji Nozomu   Ozawa Akira   Miura Noriyoshi   Yanagihara Yutaka   Sasaki Toyokazu   Nishida Takayasu   Kikugawa Tadahiko   Ikeda Tetsuhiro   Ochi Tatsumasa   Shimamoto Kenji   Aoki Katsunori   Yokoyama Masayoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite

Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer

By Soga Norihito   Kise Hideaki   Arima Kiminobu   Sugimura Yoshiki  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 376-381

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

By Kroep J.   Smit E.   Giaccone G.   Born K.   Beijnen J.   Groeningen C.   Vijgh W.   Postmus P.   Pinedo H.   Peters G.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 509-516

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin, Methotrexate and Mitoxantrone in Patients with Metastatic or Advanced Urothelial Cancer

By Andersen Lisbeth J.   Sengeløv Lisa   Kamby Claus   von der Maase Hans  

Acta Oncologica, Vol. 37, Iss. 1, 1998-05 ,pp. : 110-112

Informa Healthcare

Access to resources Recommend Favorite

Combined chemotherapy with gemcitabine and carboplatin for metastatic urothelial carcinomas in patients with high renal insufficiency

By Tanji Nozomu   Fukumoto Tetsuya   Miura Noriyoshi   Yanagihara Yutaka   Shirato Akitomi   Azuma Koji   Miyauchi Yuki   Kikugawa Tadahiko   Shimamoto Kenji   Yokoyama Masayoshi  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 910-915

Springer Publishing Company

Access to resources Recommend Favorite